Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
Stock Snapshot
Insmed Incorporated(INSM) stock is priced at $127.95, giving the company a market capitalization of 37.62B. It carries a P/E multiple of -32.22.
As of 2026-08-13, Insmed Incorporated(INSM) stock has fluctuated between $127.67 and $133.16. The current price stands at $127.95, placing the stock +0.2% above today's low and -3.9% off the high.
Insmed Incorporated(INSM) shares are trading with a volume of 400.88K, against a daily average of 4.39M.
In the last year, Insmed Incorporated(INSM) shares hit a 52-week high of $212.75 and a 52-week low of $90.39.
In the last year, Insmed Incorporated(INSM) shares hit a 52-week high of $212.75 and a 52-week low of $90.39.
INSM News
Insmed Incorporated recently reported second-quarter 2026 earnings, showing a net loss of US$13.24 million versus US$321.69 million a year earlier, and a basic...
Reports of burnout inside big AI and automation firms are clashing with promises of effortless productivity, and that gap is where investors should pay attentio...
Truist raised the firm’s price target on Insmed (INSM) to $195 from $185 and keeps a Buy rating on the shares. The firm cites the company’s strong Q2 results, d...
Analyst ratings
100%
of 25 ratingsMore INSM News
Advertisement Why Insmed Stock Is Back In Focus After Q2 Earnings Insmed (INSM) has moved back into the spotlight after second quarter 2026 earnings on 6 Augu...
Ritu Baral, an analyst from TD Cowen, maintained the Buy rating on Insmed. The associated price target is $243.00. Unlock powerful investing tools with TipRank...
Insmed stock has surged over the past three years, yet the broader valuation checks currently point to a mixed picture rather than a clear bargain or clear over...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.